PADGETT PARKER: Open Payments
NPI 1083158802 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 36 payments from 11 companies in 2025. Trend: 2023 $19 · 2024 $468 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $178 |
| UCB, Inc. | 6 | $154 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| GlaxoSmithKline, LLC. | 5 | $97 |
| ABBVIE INC. | 4 | $77 |
| Janssen Biotech, Inc. | 3 | $75 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| PFIZER INC. | 2 | $33 |
| ANI Pharmaceuticals, Inc. | 1 | $29 |
| Genentech USA, Inc. | 1 | $20 |
Products named: Bimzelx, BENLYSTA, TREMFYA, COSENTYX, KRYSTEXXA, ENBREL, RINVOQ, ORENCIA.
Industry payments across TX — which companies pay providers there.
